Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

PCOS is a hormonal disorder causing infertility and menstrual problems, often linked to obesity and can lead to acne, treated with hormonal and insulin-sensitizing medications.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

PCOS is a common hormonal disorder in women that can be managed with lifestyle changes and various medications.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Removing both ovaries treated the woman's excess male hormone symptoms.

Over a third of women thought to have non-classical congenital adrenal hyperplasia didn't have it confirmed by genetic tests.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.